腾药Tengyao品牌怎么样 申请店铺
云南腾药制药股份有限公司(以下简称“腾药”)成立于1956年，1997年改为股份合作制企业，2011年9月在县委政府的关心支持下完成股份制改造，同年11月与北京中证万融医药投资集团实现战略合作。
历经五十多年历史积淀的腾药，目前在编在岗员工600余人(含销售人员)，具备了雄厚的制药技术基础，公司在不断汲取现代科学技术的基础上具备了专业的检测手段。两者的有机结合，使“腾药”产品有了过硬的质量，造就的品种有心脉隆注射液、安宫牛黄丸、人参再造丸、六味地黄丸、六灵丸、藿香正气水、感冒疏风片、清肺抑火片等。年生产规模为2000多吨，主要剂型有注射剂、丸剂(大蜜丸、小蜜丸、水丸、水蜜丸)、片剂、颗粒剂、散剂、酒剂、酊剂、糖浆剂，国药准字批文 130个，87个品种，137个品规，均是中药、天然药物。其中，国家二类新药“心脉隆注射液”由企业与大理学院联合研制，于2007年获准生产上市，为腾药的发展注入了新的活力。
规划：发展为以心脉隆注射液为主，传统普药为辅，日化保健品为补的上市企业。
党建：公司党总支下设5个党支部，共有党员62名(其中女党员37名)。
文化：公司起源于药王宫(建于明代天启六年)——全国中医药文化宣传教育基地，整个以求健康、传健康、学健康、食健康为主。公司秉承诚信制药，争做百年腾药。公司核心使命：“为人类健康创造卓越价值”，核心价值：“顾客第一服务他人 诚信 创新”。
诚信：公司一直秉承诚信制药的优良传承，用“宁为上药三分利，莫负良医九折肱”的对联警醒着一代又一代制药人。
创新：以心脉隆注射液为主的科研课题研究、美蠊系列日化保健品开发。
Yunnan tengyao Pharmaceutical Co., Ltd. (hereinafter referred to as "tengyao") was founded in 1956, changed into a joint-stock cooperative enterprise in 1997, completed the joint-stock transformation in September 2011 with the care and support of the county Party committee and government, and achieved strategic cooperation with Beijing Zhongzheng Wanrong pharmaceutical investment group in November of the same year. After more than 50 years of historical accumulation, tengyao has more than 600 employees (including sales staff) on the job at present, with a strong pharmaceutical technology foundation, and the company has a professional testing method based on continuous learning of modern science and technology. The organic combination of the two makes the "tengyao" products have excellent quality. The varieties created are Xinmailong injection, Angongniuhuang pill, Renshen Zaizai pill, Liuwei Dihuang pill, Liuling pill, Huoxiang Zhengqi water, Ganmao Shufeng tablet, Qingfei Yihuo tablet, etc. The annual production scale is more than 2000 tons, and the main dosage forms are injection, pill (big honey pill, small honey pill, water pill, water honey pill), tablet, granule, powder, liquor, tincture, syrup. There are 130 national drug approval documents, 87 varieties, 137 product specifications, all of which are traditional Chinese medicine and natural medicine. Among them, Xinmailong injection, a national second-class new drug, was jointly developed by the enterprise and Dali University, and was approved for production and listing in 2007, which injected new vitality into the development of tengyao. Planning: to develop into a listed enterprise mainly with Xinmailong injection, supplemented by traditional general medicine and supplemented by daily chemical health products. Party Construction: the company has 5 party branches under the general Party branch, with 62 party members (including 37 female party members). Culture: the company originated in the palace of Medicine (built in the sixth year of Tianqi in Ming Dynasty) - the national base of traditional Chinese medicine culture publicity and education, focusing on health, transmission, learning and eating. The company adheres to the integrity of pharmaceutical, striving to be a century drug. The company's core mission: "to create outstanding value for human health", and its core value: "customer first, serve others and innovate with integrity". Integrity: the company has always been adhering to the good heritage of integrity pharmaceutical, with the couplet of "better for the third profit of the drug, better for the nine fold arm" to alert generations of pharmaceutical people. Innovation: Research on Xinmailong injection as the main scientific research topic, and development of Periplaneta americana series of daily chemical health products.
本文链接： https://brand.waitui.com/19813d252.html 联系电话：08755133464
浙公网安备 33010502005734号
